Connection

JOHN KNIGHT to Asthma

This is a "connection" page, showing publications JOHN KNIGHT has written about Asthma.
Connection Strength

1.193
  1. STAT6 Blockade Abrogates Aspergillus-Induced Eosinophilic Chronic Rhinosinusitis and Asthma, A Model of Unified Airway Disease. Front Immunol. 2022; 13:818017.
    View in: PubMed
    Score: 0.439
  2. Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040.
    View in: PubMed
    Score: 0.337
  3. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212.
    View in: PubMed
    Score: 0.284
  4. Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis. Immun Inflamm Dis. 2018 06; 6(2):264-275.
    View in: PubMed
    Score: 0.084
  5. Proinflammatory role for let-7 microRNAS in experimental asthma. J Biol Chem. 2010 Sep 24; 285(39):30139-49.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.